Mutant KRAS-Induced Expression of ICAM-1 in Pancreatic Acinar Cells Causes Attraction of Macrophages to Expedite the Formation of Precancerous Lesions

被引:165
作者
Liou, Geou-Yarh [1 ]
Doeppler, Heike [1 ]
Necela, Brian [1 ]
Edenfield, Brandy [1 ]
Zhang, Lizhi [2 ]
Dawson, David W. [3 ]
Storz, Peter [1 ]
机构
[1] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
关键词
NF-KAPPA-B; ADHESION MOLECULE-1 ICAM-1; MOUSE MODEL; K-RAS; DUCTAL ADENOCARCINOMA; ONCOGENIC KRAS; STELLATE CELLS; CANCER; MICE; ACTIVATION;
D O I
10.1158/2159-8290.CD-14-0474
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Desmoplasia and an inflammatory environment are defining features of pancreatic cancer. Unclear is how pancreatic cells that undergo oncogenic transformation can cross-talk with immune cells and how this contributes to the development of pancreatic lesions. Here, we demonstrate that pancreatic acinar cells expressing mutant KRAS can expedite their transformation to a duct-like phenotype by inducing local inflammation. Specifically, we show that KRAS(G12D) induces the expression of intercellular adhesion molecule-1 (ICAM-1), which serves as chemoattractant for macrophages. Infiltrating macrophages amplify the formation of KRAS(G12D)-caused abnormal pancreatic structures by remodeling the extracellular matrix and providing cytokines such as TNF. Depletion of macrophages or treatment with a neutralizing antibody for ICAM-1 in mice expressing oncogenic Kras under an acinar cell-specifi c promoter resulted in both a decreased formation of abnormal structures and decreased progression of acinar-to-ductal metaplasia to pancreatic intraepithelial neoplastic lesions. SIGNIFICANCE: We here show that oncogenic KRAS in pancreatic acinar cells upregulates the expression of ICAM-1 to attract macrophages. Hence, our results reveal a direct cooperative mechanism between oncogenic Kras mutations and the inflammatory environment to drive the initiation of pancreatic cancer. (C)2014 AACR.
引用
收藏
页码:52 / 63
页数:12
相关论文
共 50 条
[1]   MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling [J].
Ahmad, Rehan ;
Raina, Deepak ;
Trivedi, Vishal ;
Ren, Jian ;
Rajabi, Hasan ;
Kharbanda, Surender ;
Kufe, Donald .
NATURE CELL BIOLOGY, 2007, 9 (12) :1419-U146
[2]  
Amura CR, 1998, J IMMUNOL, V161, P2552
[3]   A Starring Role for Stellate Cells in the Pancreatic Cancer Microenvironment [J].
Apte, Minoti V. ;
Wilson, Jeremy S. ;
Lugea, Aurelia ;
Pandol, Stephen J. .
GASTROENTEROLOGY, 2013, 144 (06) :1210-1219
[4]   EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis [J].
Ardito, Christine M. ;
Gruener, Barbara M. ;
Takeuchi, Kenneth K. ;
Lubeseder-Martellato, Clara ;
Teichmann, Nicole ;
Mazur, Pawel K. ;
DelGiorno, Kathleen E. ;
Carpenter, Eileen S. ;
Halbrook, Christopher J. ;
Hall, Jason C. ;
Pal, Debjani ;
Briel, Thomas ;
Herner, Alexander ;
Trajkovic-Arsic, Marija ;
Sipos, Bence ;
Liou, Geou-Yarh ;
Storz, Peter ;
Murray, Nicole R. ;
Threadgill, David W. ;
Sibilia, Maria ;
Washington, M. Kay ;
Wilson, Carole L. ;
Schmid, Roland M. ;
Raines, Elaine W. ;
Crawford, Howard C. ;
Siveke, Jens T. .
CANCER CELL, 2012, 22 (03) :304-317
[5]   Epidermal Growth Factor-Like Domain 7 Suppresses Intercellular Adhesion Molecule 1 Expression in Response to Hypoxia/Reoxygenation Injury in Human Coronary Artery Endothelial Cells [J].
Badiwala, Mitesh V. ;
Tumiati, Laura C. ;
Joseph, Jemy M. ;
Sheshgiri, Rohit ;
Ross, Heather J. ;
Delgado, Diego H. ;
Rao, Vivek .
CIRCULATION, 2010, 122 (11) :S156-S161
[6]   Pancreatic cancer biology and genetics [J].
Bardeesy, N ;
DePinho, RA .
NATURE REVIEWS CANCER, 2002, 2 (12) :897-909
[7]   Plectin-1 as a Novel Biomarker for Pancreatic Cancer [J].
Bausch, Dirk ;
Thomas, Stephanie ;
Mino-Kenudson, Mari ;
Fernandez-del Castillo, Carlos ;
Bauer, Todd W. ;
Williams, Mark ;
Warshaw, Andrew L. ;
Thayer, Sarah P. ;
Kelly, Kimberly A. .
CLINICAL CANCER RESEARCH, 2011, 17 (02) :302-309
[8]   CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans [J].
Beatty, Gregory L. ;
Chiorean, Elena G. ;
Fishman, Matthew P. ;
Saboury, Babak ;
Teitelbaum, Ursina R. ;
Sun, Weijing ;
Huhn, Richard D. ;
Song, Wenru ;
Li, Dongguang ;
Sharp, Leslie L. ;
Torigian, Drew A. ;
O'Dwyer, Peter J. ;
Vonderheide, Robert H. .
SCIENCE, 2011, 331 (6024) :1612-1616
[9]   Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice [J].
Burns, RC ;
Rivera-Nieves, J ;
Moskaluk, CA ;
Matsumoto, S ;
Cominelli, F ;
Ley, K .
GASTROENTEROLOGY, 2001, 121 (06) :1428-1436
[10]   Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice [J].
Collins, Meredith A. ;
Bednar, Filip ;
Zhang, Yaqing ;
Brisset, Jean-Christophe ;
Galban, Stefanie ;
Galban, Craig J. ;
Rakshit, Sabita ;
Flannagan, Karen S. ;
Adsay, N. Volkan ;
di Magliano, Marina Pasca .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (02) :639-653